Evidence map›Paper›PMID 34532828›Full record

ArticleActa neurologica Belgica2022

Communicating the diagnosis: a survey of patients with amyotrophic lateral sclerosis and their families in Japan.

Takehisa Hirayama, Yuishin Izumi, Yuki Nakayama, Mari Shibukawa, Satoru Ebihara, Osamu Kano

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takehisa HirayamaDepartment of Neurology, Toho University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3056-3176
Yuishin IzumiDepartment of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yuki NakayamaUnit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Mari ShibukawaDepartment of Neurology, Toho University Faculty of Medicine, Tokyo, Japan.
Satoru EbiharaDepartment of Rehabilitation Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
Osamu KanoDepartment of Neurology, Toho University Faculty of Medicine, Tokyo, Japan. osamu.kano@med.toho-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the needs of patients with amyotrophic lateral sclerosis (ALS) and their families when being communicated the diagnosis.

methodsWe held a nationwide webinar in September 2020, titled "ALS Café", and distributed a self-report questionnaire to participants. PATIENTS: This cross-sectional study included 56 respondents (patients, n = 32; family members, n = 24).

resultsOf the 56 respondents, 47 (84%) reported being anxious when they were communicated their diagnosis. The average time allocated for communicating the diagnosis was 36.3 ± 25.6 min, and 30% of respondents believed that insufficient time was allocated. Nearly half of the respondents were communicated their diagnosis by one physician, and 57% of the respondents received their diagnosis in one session. Approximately 80% of respondents received information about ventilators when they were being communicated their diagnosis, but most patients did not want to receive this information at that time. The anxious group tended to answer that the time to communicate the diagnosis was short. Meanwhile, all respondents in the mildly anxious group were provided with one or more information about the supportive contents along with the diagnosis. Moreover, in Japan, many patients with ALS and their families desire the legalization of euthanasia, which might affect decision-making.

conclusionsThis study shows that a longer amount of time spent communicating the diagnosis and provision of descriptions needed by patients and their families are important. This can help clinicians understand what the patient requires while being communicated their diagnosis.

Indexed as

Amyotrophic Lateral SclerosisCross-Sectional StudiesHumansJapanSurveys and QuestionnairesAmyotrophic lateral sclerosisCommunicating a diagnosisEuthanasiaTracheostomy and invasive ventilatorWebinar

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.